161 related articles for article (PubMed ID: 20075037)
21. Open lung-sparing surgery for malignant pleural mesothelioma: the benefits of a radical approach within multimodality therapy.
Nakas A; Trousse DS; Martin-Ucar AE; Waller DA
Eur J Cardiothorac Surg; 2008 Oct; 34(4):886-91. PubMed ID: 18656373
[TBL] [Abstract][Full Text] [Related]
22. Malignant pleural mesothelioma: clinicopathologic and survival characteristics in a consecutive series of 394 patients.
Borasio P; Berruti A; Billé A; Lausi P; Levra MG; Giardino R; Ardissone F
Eur J Cardiothorac Surg; 2008 Feb; 33(2):307-13. PubMed ID: 18164622
[TBL] [Abstract][Full Text] [Related]
23. A phase II study of intrapleural immunochemotherapy, pleurectomy/decortication, radiotherapy, systemic chemotherapy, and long-term subcutaneous IL-2 in stage II-III malignant pleural mesothelioma.
Rusch VW
Eur J Cardiothorac Surg; 2007 Mar; 31(3):534-5. PubMed ID: 17267238
[No Abstract] [Full Text] [Related]
24. Is less also better? A single-institution experience on treatment of early stage Malignant Pleural Mesothelioma.
Bertoglio P; Ambrogi MC; Chella A; Aprile V; Dini P; Korasidis S; Fanucchi O; Mussi A
Eur J Surg Oncol; 2017 Jul; 43(7):1365-1371. PubMed ID: 28274663
[TBL] [Abstract][Full Text] [Related]
25. Case-control study between extrapleural pneumonectomy and radical pleurectomy/decortication for pathological N2 malignant pleural mesothelioma.
Martin-Ucar AE; Nakas A; Edwards JG; Waller DA
Eur J Cardiothorac Surg; 2007 May; 31(5):765-70; discussion 770-1. PubMed ID: 17337201
[TBL] [Abstract][Full Text] [Related]
26. Induction of apoptosis by intrapleural perfusion hyperthermo-chemotherapy for malignant pleural mesothelioma.
Matsuzaki Y; Tomita M; Shimizu T; Hara M; Ayabe T; Onitsuka T
Ann Thorac Cardiovasc Surg; 2008 Jun; 14(3):161-5. PubMed ID: 18577894
[TBL] [Abstract][Full Text] [Related]
27. [Multimodal therapy for malignant pleural mesothelioma including extrapleural pneumonectomy].
Sienel W; Kirschbaum A; Passlick B
Zentralbl Chir; 2008 Jun; 133(3):231-7. PubMed ID: 18563687
[TBL] [Abstract][Full Text] [Related]
28. The role of muscle flap in preventing bronchus stump insufficiency after pneumonectomy for malignant pleural mesothelioma in high-risk patients.
Beshay M; Carboni G; Hoksch B; Reymond MA; Schmid RA
Interact Cardiovasc Thorac Surg; 2008 Aug; 7(4):621-4; discussion 624-5. PubMed ID: 18381361
[TBL] [Abstract][Full Text] [Related]
29. Adjuvant therapy for malignant pleural mesothelioma.
Keller SM
Chest Surg Clin N Am; 1994 Feb; 4(1):127-35. PubMed ID: 8055277
[TBL] [Abstract][Full Text] [Related]
30. [Therapeutic options in malignant pleural mesothelioma].
Serke M; Loddenkemper R
Pneumologie; 2005 May; 59(5):337-48. PubMed ID: 15902599
[TBL] [Abstract][Full Text] [Related]
31. Surgical treatment in the management of malignant pleural mesothelioma: a single institution's experience.
van Sandick JW; Kappers I; Baas P; Haas RL; Klomp HM
Ann Surg Oncol; 2008 Jun; 15(6):1757-64. PubMed ID: 18398658
[TBL] [Abstract][Full Text] [Related]
32. Limited cardiotoxicity after extensive thoracic surgery and intraoperative hyperthermic intrathoracic chemotherapy with doxorubicin and cisplatin.
de Bree E; van Ruth S; Schotborgh CE; Baas P; Zoetmulder FA
Ann Surg Oncol; 2007 Oct; 14(10):3019-26. PubMed ID: 17638057
[TBL] [Abstract][Full Text] [Related]
33. Thoracic stop-flow perfusion in the treatment of refractory malignant pleural mesothelioma: a phase I-II evaluation/trial.
Guadagni S; Clementi M; Valenti M; Fiorentini G; Cantore M; Kanavos E; Amicucci G
In Vivo; 2006; 20(6A):715-8. PubMed ID: 17203752
[TBL] [Abstract][Full Text] [Related]
34. Hyperthermia combined with intra-thoracic chemotherapy and radiotherapy for malignant pleural mesothelioma.
Xia H; Karasawa K; Hanyu N; Chang TC; Okamoto M; Kiguchi Y; Kawakami M; Itazawa T
Int J Hyperthermia; 2006 Nov; 22(7):613-21. PubMed ID: 17079218
[TBL] [Abstract][Full Text] [Related]
35. Cytoreductive surgery and hyperthermic intrathoracic chemotherapy perfusion for malignant pleural tumours: perioperative management and clinical experience.
Ried M; Potzger T; Braune N; Neu R; Zausig Y; Schalke B; Diez C; Hofmann HS
Eur J Cardiothorac Surg; 2013 Apr; 43(4):801-7. PubMed ID: 22885228
[TBL] [Abstract][Full Text] [Related]
36. Surgical techniques for multimodality treatment of malignant pleural mesothelioma: extrapleural pneumonectomy and pleurectomy/decortication.
Wolf AS; Daniel J; Sugarbaker DJ
Semin Thorac Cardiovasc Surg; 2009; 21(2):132-48. PubMed ID: 19822285
[TBL] [Abstract][Full Text] [Related]
37. Symptomatic and quality of life changes after extrapleural pneumonectomy for malignant pleural mesothelioma.
Ambrogi V; Mineo D; Gatti A; Pompeo E; Mineo TC
J Surg Oncol; 2009 Sep; 100(3):199-204. PubMed ID: 19274670
[TBL] [Abstract][Full Text] [Related]
38. Multimodality treatment of malignant pleural mesothelioma with or without immunotherapy: does it change anything?
Lucchi M; Picchi A; Alí G; Chella A; Guglielmi G; Cristaudo A; Fontanini G; Mussi A
Interact Cardiovasc Thorac Surg; 2010 Apr; 10(4):572-6. PubMed ID: 20053697
[TBL] [Abstract][Full Text] [Related]
39. [Treatment of malignant pleural mesothelioma].
Yusa T
Gan To Kagaku Ryoho; 2007 Apr; 34(4):520-6. PubMed ID: 17431335
[TBL] [Abstract][Full Text] [Related]
40. Hyperthermic chemoperfusion for the treatment of malignant pleural mesothelioma.
Mujoomdar AA; Sugarbaker DJ
Semin Thorac Cardiovasc Surg; 2008; 20(4):298-304. PubMed ID: 19251168
[TBL] [Abstract][Full Text] [Related]
[Previous] [Next] [New Search]
